Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | HLA-J///HLA-H///HLA-G///HLA-B///HLA-A |
| Upstream (Parents) |
|---|
| (<<) HLA-DRA → HLA-J///HLA-H///HLA-G///HLA-B///HLA-A |
| (<<) HLA-G → HLA-J///HLA-H///HLA-G///HLA-B///HLA-A |
| (<<) PSAP → HLA-J///HLA-H///HLA-G///HLA-B///HLA-A |
| Downstream (Children) |
|---|
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → PSMB10 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → PDLIM5 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → HLA-C (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → C5orf42 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → RARRES3 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → HLA-B (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → HLA-G (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → CYP4F11 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → PLXNA2 (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → IL17RB (>>) |
| HLA-J///HLA-H///HLA-G///HLA-B///HLA-A → LOC391020 (>>) |
